Novo Nordisk Down, GSK Departure, Lufthansa Up
On this episode of Stock Movers: - Novo Nordisk fell as Morgan Stanley downgraded its rating to underweight on weaker prescription momentum for the firm’s weight-loss drugs. - GSK CEO Emma Walmsley is stepping down after almost nine years with chief commercial officer Luke Miels taking over on January 1st. - Lufthansa gained after the airline outlined new financial goals, including plans to cut 4,000 administrative jobs by 2030.See omnystudio.com/listener for privacy information.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.